Concepedia

Pamela Kearns

PK

Statistics

Publications

69

Citations

3.6K

H-Index

33

Active since

1998

Affiliations

University of Birmingham(Current)

Cancer Research UK Clinical Trials Unit

NIHR Birmingham Biomedical Research Centre

University College London

Institut Gustave Roussy

Pamela Kearns is an author at University of Birmingham specializing in medicine, oncology, and pediatric oncology.

ORCID

Publications per year

1998–2025

69

Publications

69

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

Victoria Weston, Ceri Oldreive, Anna Skowrońska et al. · Blood · 2010 · 305 citations · Full text

, , +9

The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global

Michael Sullivan, Éric Bouffet, Carlos Rodríguez‐Galindo et al. · Pediatric Blood & Cancer · 2020 · 164 citations · Full text

, , +7

Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target

Francis Mussai, Sharon A. Egan, Joseph Higginbotham-Jones et al. · Blood · 2015 · 160 citations · Full text

, , +15

Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia

Charlotte V. Cox, H Martin, Pamela Kearns et al. · Blood · 2006 · 151 citations · Full text

, , +14

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe et al. · Nature Medicine · 2023 · 133 citations · Full text

, , +17

1–5 of 69